Thousands to benefit as prostate cancer drug approved for use on the NHS
Reading now: 516
manchestereveningnews.co.ukDon't miss a thing by getting the day's biggest stories sent direct to your inbox Thousands of men are to benefit from a new prostate cancer drug that has been approved for use on the NHS.
The National Institute for Health and Care Excellence (Nice) has recommended enzalutamide as an option for treating some types of prostate cancer.
Prostate Cancer UK has welcomed the news, especially for those who are unable to have chemotherapy. The drug is a so-called 'Covid-friendly' cancer drug, which patients have been able to take in the comfort of their own home, instead of needing intravenous medication in a health setting.
Now, new draft guidance from Nice should enable wider use. The guidance says that the drug, also known as Xtandi and made by
Read more on manchestereveningnews.co.uk
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
